France's main Braille publisher is in financial crisis after a bold decision to sell its embossed books for the same price as standard ones. Its future raises the broader question of whether printed ...
BBC Creator Lab has returned with a brand-new opportunity for gardening and horticulture-focused digital creators, delivered ...
Digital Camera World on MSN
This might be boring, but it's my most essential new year’s photography tip
A neat trick is to use the ‘File info’ menu option in Photoshop, which usually lists the serial numbers as well as the model ...
Wigan Today on MSNOpinion
Tony Porter Ponders : The Bell what will happen and an anniversary.
This year will be make or break for the Bell, have the council leant their lesson yet? Plus an anniversary that caught me out ...
Right now, you can secure a lifetime subscription to PDF Converter and Editor for just $23.99 (reg. $99.99) with code CONVERT ...
PDFs are arguably one of the most-used document formats by professionals, students and casual users alike. However, while they might be the best way to transmit documents, they’re not entirely easy to ...
PDF files have become ubiquitous in our multi-platform world. This convenient file format makes it possible to view and share documents across various devices using various operating systems and ...
Hosted on MSN
PDF editing made easy forever for just $40
TL;DR: PDF Agile gives Windows users a fast, full-featured PDF editor—complete with OCR, conversion tools, security features, and annotation—for a one-time $39.99 payment. If you spend any amount of ...
Adobe Acrobat’s popularity is a given because of its advanced editing features. But it’s also pricey, lags with big files sometimes, and is packed with features you might never use. Plenty of users ...
ASX-listed Bayan Mining and Minerals has strengthened its US rare earths push with the appointment of veteran processing and ...
AstraZeneca’s rare disease firm Alexion is set to expand its genomic medicine portfolio with the acquisition of gene editing specialist LogicBio Therapeutics, in a deal worth approximately $68 million ...
Gene-editing specialist Editas Medicine has halted development of its lead clinical programme for congenital eye disorders after it generated lacklustre results in a phase 1/2 trial. The BRILLIANCE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback